FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Paykel Neela		 2. Issuer Name and Ticker or Trading Symbol

Hyperfine, Inc. [ HYPR ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Gen Counsel & Corp Secretary
(Last)          (First)          (Middle)

C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET		 3. Date of Earliest Transaction (MM/DD/YYYY)

10/31/2022
(Street)

GUILFORD, CT 06437
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) $3.90 10/31/2022  D (1)    71750   (1)2/9/2032 Class A Common Stock 71750  (1)0 D  
Stock Option (right to buy) $0.91 10/31/2022  A (1)  71750     (1)2/9/2032 Class A Common Stock 71750  (1)71750 D  
Stock Option (right to buy) $3.90 10/31/2022  D (2)    85000   (2)2/9/2032 Class A Common Stock 85000  (2)0 D  
Stock Option (right to buy) $0.91 10/31/2022  A (2)  85000     (2)2/9/2032 Class A Common Stock 85000  (2)85000 D  
Stock Option (right to buy) $3.27 10/31/2022  D (3)    98250   (3)4/27/2031 Class A Common Stock 98250  (3)0 D  
Stock Option (right to buy) $0.91 10/31/2022  A (3)  98250     (3)4/27/2031 Class A Common Stock 98250  (3)98250 D  
Explanation of Responses:
(1) The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.
(2) The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.
(3) The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Paykel Neela
C/O HYPERFINE, INC.
351 NEW WHITFIELD STREET
GUILFORD, CT 06437

Gen Counsel & Corp Secretary
Signatures
/s/ Alok Gupta11/1/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Hyperfine (NASDAQ:HYPR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Hyperfine Charts.
Hyperfine (NASDAQ:HYPR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Hyperfine Charts.